STOCK TITAN

Spectral AI, Inc. - MDAI STOCK NEWS

Welcome to our dedicated page for Spectral AI news (Ticker: MDAI), a resource for investors and traders seeking the latest updates and insights on Spectral AI stock.

Spectral AI, Inc. (Nasdaq: MDAI) is an artificial intelligence company dedicated to advancing medical diagnostics, particularly in wound care. The company's flagship product, the DeepView™ System, is a cutting-edge multispectral imaging (MSI) device designed to assist physicians in making accurate and timely treatment decisions. This innovative technology leverages proprietary algorithms to differentiate between damaged and healthy tissue, producing critical Day One healing assessments within seconds.

Spectral AI's DeepView System has received FDA Breakthrough Device Designation due to its potential to significantly improve patient outcomes. The primary focus of the company lies in the research and development of this system. Notably, a substantial portion of its funding comes from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services.

In recent developments, Spectral AI was honored with the Commitment to Quality Achievement Award by the Texas Manufacturer Assistance Center (TMAC) for their attainment of the UKCA Mark. This accolade underscores the company’s dedication to maintaining the highest standards of quality while working towards the commercialization of DeepView technology.

The company frequently updates its stakeholders through conference calls and presentations, which can be accessed via the investor relations section of its website. This proactive communication strategy ensures transparency and keeps investors well-informed about the company's progress and financial health.

Investor Relations Contacts:

Devin Sullivan, Managing Director at The Equity Group, can be reached at dsullivan@equityny.com.

Conor Rodriguez, Analyst at The Equity Group, can be contacted at crodriguez@equityny.com.

Media Contacts:

David Schull of Russo Partners can be reached at david.schull@russopartnersllc.com or (858) 717-2310.

Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) announced a $1 million investment from its largest shareholder into its subsidiary Spectral IP, focusing on advancing intellectual property in the AI ecosystem. The investment aims to unlock additional value for shareholders and accelerate innovation in medical diagnostics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.66%
Tags
AI
-
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) will report financial results for Q4 and full year 2023 on March 27, 2024. The company focuses on AI medical diagnostics for wound care. Investors can join the conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.05%
Tags
-
Rhea-AI Summary
Spectral AI, Inc. (MDAI) secures a new $500,000 contract with the Defense Health Agency and the US Army Medical Material Development Activity for the development of the handheld version of DeepView™ Wound Imaging System. The Company has received over $149 million in non-dilutive financing in the past six months, bringing the total government support to over $250 million. The contract aims to optimize the device's functionality and size for combat readiness and potential use in home health care, reinforcing Spectral AI's position as a leader in AI-driven healthcare innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.56%
Tags
AI
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) forms a subsidiary to focus on advancing intellectual property in the AI healthcare sector, aiming to enhance shareholder value through patents and trade secrets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.18%
Tags
AI
-
Rhea-AI Summary
Spectral AI, Inc. appoints Peter M. Carlson as CEO, transitioning Wensheng Fan to Chief Innovation Strategist. The Company announces preliminary 2023 R&D revenue of $18 million and reaffirms $28 million revenue guidance for 2024. Spectral AI highlights first quarter momentum and key milestones in commercialization of AI-powered wound care technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
management AI
-
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) announces participation in investor conferences to showcase their AI technology for medical diagnostics in wound care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.1%
Tags
conferences AI
Rhea-AI Summary
Spectral AI, Inc. (MDAI) announces the UKCA authorization for its DeepView AI®-Burn predictive software, allowing for faster burn wound diagnosis. Revenue from UK commercialization in 2024 is expected to contribute to the Company's $28 million revenue guidance. The technology boasts 92% accuracy in distinguishing healthy and damaged tissue, potentially revolutionizing burn wound management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
none
-
Rhea-AI Summary
Spectral AI, Inc. appoints Dr. J. Michael DiMaio to its Board of Directors, extending lock-up agreements for major stockholders. Dr. DiMaio brings extensive medical and research expertise to support the company's AI-driven wound imaging technology platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.13%
Tags
management AI
-
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024. The company will host investor meetings during the conference, offering an opportunity for virtual or in-person meetings. This event aims to showcase Spectral AI's focus on medical diagnostics for wound care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.67%
Tags
conferences AI
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) announced a Letter to Shareholders detailing the Company's progress towards commercializing its AI-driven DeepView System for wound assessment and treatment. The letter highlights a $149 million contract from BARDA, revenue generation expectations, FDA and UKCA marking for proprietary technology, promising interim results for DFU Clinical Study, and new management appointments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
AI

FAQ

What is the current stock price of Spectral AI (MDAI)?

The current stock price of Spectral AI (MDAI) is $1.34 as of September 6, 2024.

What is the market cap of Spectral AI (MDAI)?

The market cap of Spectral AI (MDAI) is approximately 23.8M.

What does Spectral AI, Inc. specialize in?

Spectral AI specializes in AI-based medical diagnostics, particularly focusing on wound care through their DeepView System.

What is the DeepView System?

The DeepView System is a multispectral imaging device that uses AI algorithms to distinguish between damaged and healthy tissue, aiding in quicker and more accurate treatment decisions.

Has the DeepView System received any regulatory recognition?

Yes, the DeepView System has received FDA Breakthrough Device Designation.

Where does Spectral AI get its research funding?

A substantial portion of Spectral AI's funding comes from the Biomedical Advanced Research and Development Authority (BARDA).

What recent award has Spectral AI received?

Spectral AI recently received the Commitment to Quality Achievement Award from the Texas Manufacturer Assistance Center.

How can investors stay updated on Spectral AI's progress?

Investors can stay updated through conference calls and presentations available on the investor relations section of the company's website.

Who are the media contacts for Spectral AI?

David Schull of Russo Partners, reachable at david.schull@russopartnersllc.com or (858) 717-2310, is the media contact.

What is the role of BARDA in Spectral AI's operations?

BARDA provides essential research and development funding for Spectral AI's projects.

What kind of assessments does the DeepView System provide?

The DeepView System provides Day One healing assessments, allowing for accurate and timely treatment decisions.

Who are the investor relations contacts at Spectral AI?

Devin Sullivan, Managing Director, and Conor Rodriguez, Analyst, both at The Equity Group, are the investor relations contacts.

Spectral AI, Inc.

Nasdaq:MDAI

MDAI Rankings

MDAI Stock Data

23.77M
17.61M
46.74%
21.01%
3.38%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
DALLAS